Status:
TERMINATED
Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis
Lead Sponsor:
Hvidovre University Hospital
Collaborating Sponsors:
Chr Hansen
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether the lactic acid bacteria " Lactobacillus acidophilus (LA5) and Bifidobacterium animalis subsp. lactis (BB12)" is effective as maintenance treatment in...
Eligibility Criteria
Inclusion
- Patients with ulerative colitis ording to well-known diagnostic criteria and remission for at least one month, and with at least one relapse within the last year.
Exclusion
- Pregnancy and lactating
- Serious underlying disease other than UC
- Former gastrointestinal resections
- Medication for UC other than mesalazine
- Known allergic reactions towards compounds in the study drug.
- Expected lack of compliance due to mental state or language problems
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00268164
Start Date
June 1 2004
End Date
March 1 2007
Last Update
May 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Medical Gastroenterology
Hvidovre, Hvidovre, Denmark, 2650